Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Splenectomy in hairy cell leukemia].

M Schnorrer1, J Pechan, T Lipsic

  • 1Chirurgickej kliniky NsP Bezrucova v Bratislave.

Bratislavske Lekarske Listy
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI‑based neoadjuvant therapy indication in middle and low rectal cancer.

Bratislavske lekarske listy·2019
Same author

Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.

Neoplasma·2019
Same author

Early versus delayed laparoscopic cholecystectomy in treatment of acute cholecystitis.

Bratislavske lekarske listy·2016
Same author

[Optimal timing of laparoscopic cholecystectomy in treatment of acute cholecystitis].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2016
Same author

Importance of thymectomy and prognostic factors in the complex treatment of myasthenia gravis.

Bratislavske lekarske listy·2016
Same author

Laparoscopic versus open appendectomy in treatment of acute appendicitis.

Bratislavske lekarske listy·2015

Splenectomy is a viable primary treatment for hairy cell leukemia. Four out of five patients survived disease-free for 2-7 years post-surgery, indicating its effectiveness.

Area of Science:

  • Hematology
  • Surgical Oncology

Background:

  • Hairy cell leukemia (HCL) is a rare, chronic B-cell malignancy.
  • Treatment options for HCL have evolved, with splenectomy being a historical consideration.

Observation:

  • A retrospective study evaluated splenectomy in five HCL patients between 1982 and 1987.
  • Patient outcomes were monitored for disease progression and survival post-operation.

Findings:

  • Four out of five patients experienced long-term survival (2-7 years) without disease relapse after splenectomy.
  • One patient succumbed to disease progression three years post-surgery.

Implications:

  • Splenectomy demonstrates potential as a primary therapeutic intervention for hairy cell leukemia.

Related Experiment Videos

  • These findings support the consideration of splenectomy in the management of HCL, warranting further investigation.